Clinical trial
Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese…
NCT00486291 · VIVUS LLC, Industry · Completed
Key facts
| NCT number | NCT00486291 |
|---|---|
| Title | Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics |
| Official title | A Phase 2, Randomized, Double Blind, Parallel Design Study Comparing the Efficacy and Safety of VI-0521 to Placebo in the Glycemic Management of Obese Diabetic Adults |
| Lead sponsor | VIVUS LLC, Industry |
| Collaborators | Synteract, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | VI-0521, Placebo |
| Enrollment | 210 |
| Start date | Jun 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jun 14, 2007 |
| Last update posted | Sep 10, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: